Knowledge Distillery

In this review, the authors discuss the evidence on occurrence of de novo seizures in patients with COVID-19, the consequences of this catastrophic…

The aim of this multicentre, European, cohort study involving 34 stroke centres in France, Italy, Spain, and Belgium, was to study early outcomes…

The severe form of COVID-19 tends to be associated with neurological deficits.

The CoronaVirus Disease 19 (COVID-19) pandemic is a threat of particular concern for people affected by chronic immune-mediated diseases, such as…

Multiple risk factors for mortality have been identified in patients with COVID-19.

Neurological manifestations are common in patients with COVID-19, but little is known about pathophysiological mechanisms. In this single-centre…

Narcolepsy type 1 (NT1) is a chronic rare hypersomnia of central origin requiring a combination of behavioural and pharmacological treatments. During…

The prolonged mechanical ventilation that is often required by patients with severe COVID-19 is expected to result in significant intensive care…

BNT162b2 is a lipid nanoparticle–formulated, nucleoside-modified RNA vaccine encoding a prefusion-stabilized, membrane-anchored severe acute…

LY-CoV555, a neutralising monoclonal antibody, has been associated with a decrease in viral load and frequency of hospitalisations or emergency…

Recent data suggest that complications and death from COVID-19 may be related to high viral loads.

The efficacy of interleukin-6 receptor blockade in hospitalised patients with COVID-19 who are not receiving mechanical ventilation is unclear.